[HTML][HTML] Hypoxia-dependent drivers of melanoma progression

S D'Aguanno, F Mallone, M Marenco… - Journal of Experimental …, 2021 - Springer
Hypoxia, a condition of low oxygen availability, is a hallmark of tumour microenvironment
and promotes cancer progression and resistance to therapy. Many studies reported the …

A 3D bioprinted in vitro model of neuroblastoma recapitulates dynamic tumor‐endothelial cell interactions contributing to solid tumor aggressive behavior

L Ning, J Shim, ML Tomov, R Liu, R Mehta… - Advanced …, 2022 - Wiley Online Library
Neuroblastoma (NB) is the most common extracranial tumor in children resulting in
substantial morbidity and mortality. A deeper understanding of the NB tumor …

[HTML][HTML] Tumor neovascularization and developments in therapeutics

Y Katayama, J Uchino, Y Chihara, N Tamiya, Y Kaneko… - Cancers, 2019 - mdpi.com
Tumors undergo fast neovascularization to support the rapid proliferation of cancer cells.
Vasculature in tumors, unlike that in wound healing, is immature and affects the tumor …

[HTML][HTML] Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis

KA Norton, AS Popel - Scientific reports, 2016 - nature.com
Angiogenesis, the recruitment of new blood vessels, is a critical process for the growth,
expansion, and metastatic dissemination of developing tumors. Three types of cells make up …

[HTML][HTML] Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

X Zhang, Y Wang, J Fan, W Chen, J Luan, X Mei… - … for immunotherapy of …, 2019 - Springer
Background Inhibitors targeting VEGF and VEGFR are commonly used in the clinic, but only
a subset of patients could benefit from these inhibitors and the efficacy was limited by …

Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): a phase II study evaluating an individualized treatment strategy for metastatic disease

DVT Catenacci, S Moya, S Lomnicki, LM Chase… - Cancer discovery, 2021 - AACR
The one-year and median overall survival (mOS) rates of advanced gastroesophageal
adenocarcinomas (GEA) are∼ 50% and< 12 months, respectively. Baseline spatial and …

Hypoxic tumor microenvironment: Implications for cancer therapy

S Roy, S Kumaravel, A Sharma… - Experimental …, 2020 - journals.sagepub.com
Hypoxia or low oxygen concentration in tumor microenvironment has widespread effects
ranging from altered angiogenesis and lymphangiogenesis, tumor metabolism, growth, and …

[HTML][HTML] Antiangiogenic cancer treatment: The great discovery and greater complexity

E Maj, D Papiernik, J Wietrzyk - … journal of oncology, 2016 - spandidos-publications.com
The discovery of tumor angiogenesis opened a new path in fighting cancer. The approval of
different antiangiogenic agents, most targeting vascular endothelial growth factor (VEGF) …

[HTML][HTML] Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2

D Keskin, J Kim, VG Cooke, CC Wu, H Sugimoto, C Gu… - Cell reports, 2015 - cell.com
Strategies to target angiogenesis include inhibition of the vessel-stabilizing properties of
vascular pericytes. Pericyte depletion in early-stage non-hypoxic tumors suppressed …

[HTML][HTML] Evaluation of angiogenesis assays

ZI Stryker, M Rajabi, PJ Davis, SA Mousa - Biomedicines, 2019 - mdpi.com
Angiogenesis assays allow for the evaluation of pro-or anti-angiogenic activity of
endogenous or exogenous factors (stimulus or inhibitors) through investigation of their pro …